Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies address cellular imbalances related to mitochondrial dysfunction and thereby modulate the immune response. They have been shown to protect neurons in models of chronic neurological diseases and improve recovery in acute neurological injury. We are partnering with internationally renowned scientists in biomedical research in a concerted effort to improve the lives of millions.
View Top Employees from Revalesio CorporationWebsite | http://revalesio.com |
Revenue | $5.3 million |
Employees | 20 (20 on RocketReach) |
Founded | 2006 |
Address | 1202 East D Street, Tacoma, Washington 98421, US |
Phone | (253) 922-2600 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Health Care, Information Technology |
Web Rank | 22 Million |
Keywords | Rns60, Revalesio |
Competitors | Destiny Pharma plc, GlycoMimetics, Lumos Pharma, Patrys Limited, Precision Biologics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Revalesio Corporation employee's phone or email?
The Revalesio Corporation annual revenue was $5.3 million in 2024.
Greg Archambeau is the President of Revalesio Corporation.
20 people are employed at Revalesio Corporation.
Revalesio Corporation is based in Tacoma, Washington.
The NAICS codes for Revalesio Corporation are [541, 54, 54171, 541714, 5417].
The SIC codes for Revalesio Corporation are [873, 87].